JPS52120117A - Viral nasal cavity bronchitis vaccine and blended vaccine with kalicivirus - Google Patents

Viral nasal cavity bronchitis vaccine and blended vaccine with kalicivirus

Info

Publication number
JPS52120117A
JPS52120117A JP3688277A JP3688277A JPS52120117A JP S52120117 A JPS52120117 A JP S52120117A JP 3688277 A JP3688277 A JP 3688277A JP 3688277 A JP3688277 A JP 3688277A JP S52120117 A JPS52120117 A JP S52120117A
Authority
JP
Japan
Prior art keywords
vaccine
kalicivirus
nasal cavity
blended
bronchitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3688277A
Other languages
English (en)
Other versions
JPS6216933B2 (ja
Inventor
Baanon Deibisu Erudon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Publication of JPS52120117A publication Critical patent/JPS52120117A/ja
Publication of JPS6216933B2 publication Critical patent/JPS6216933B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP3688277A 1976-03-30 1977-03-30 Viral nasal cavity bronchitis vaccine and blended vaccine with kalicivirus Granted JPS52120117A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/671,792 US4031204A (en) 1976-03-30 1976-03-30 Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom

Publications (2)

Publication Number Publication Date
JPS52120117A true JPS52120117A (en) 1977-10-08
JPS6216933B2 JPS6216933B2 (ja) 1987-04-15

Family

ID=24695906

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3688277A Granted JPS52120117A (en) 1976-03-30 1977-03-30 Viral nasal cavity bronchitis vaccine and blended vaccine with kalicivirus
JP61220828A Granted JPS62115279A (ja) 1976-03-30 1986-09-17 ネコ鼻腔気管炎ウイルスの大量生産方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61220828A Granted JPS62115279A (ja) 1976-03-30 1986-09-17 ネコ鼻腔気管炎ウイルスの大量生産方法

Country Status (13)

Country Link
US (1) US4031204A (ja)
JP (2) JPS52120117A (ja)
AU (1) AU510744B2 (ja)
BE (1) BE852756A (ja)
CA (1) CA1085724A (ja)
DE (1) DE2713371A1 (ja)
FR (1) FR2346022A1 (ja)
GB (1) GB1580844A (ja)
IE (1) IE44911B1 (ja)
LU (1) LU77030A1 (ja)
NL (1) NL7703197A (ja)
NZ (1) NZ183618A (ja)
ZA (1) ZA771893B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008512130A (ja) * 2004-09-13 2008-04-24 ワイス 出血性ネコカリシウイルス、カリシウイルスワクチンおよびカリシウイルス感染または疾患を予防するための方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
JPS5576819A (en) * 1978-11-30 1980-06-10 Wellcome Found Attenuated feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
JPS59501161A (ja) * 1982-06-10 1984-07-05 パ−セル・ロバ−ト・エツチ 脂質ウイルスの不活性化方法
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
CA1237668A (en) * 1983-02-25 1988-06-07 Novagene Inc. Thymidine kinase-negative temperature resistant bovine herpes-virus-1 mutant as vaccine
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
US5716822A (en) * 1989-07-21 1998-02-10 Pharmacia & Upjohn Company Feline calicivirus capsid gene and protein
ZA927037B (en) * 1991-09-30 1993-03-29 Akzo Nv Respiratory disease vaccine for cats.
GB2509940A (en) * 2013-01-18 2014-07-23 John Ogino Vaccine production via irradiation of pathogenic cultures
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259546A (en) * 1962-06-01 1966-07-05 Canadian Patents Dev Treatment of viruses
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea
CA1058074A (en) * 1974-03-25 1979-07-10 Pitman-Moore Feline rhinotracheitis vaccine and production thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008512130A (ja) * 2004-09-13 2008-04-24 ワイス 出血性ネコカリシウイルス、カリシウイルスワクチンおよびカリシウイルス感染または疾患を予防するための方法

Also Published As

Publication number Publication date
JPS62115279A (ja) 1987-05-26
NL7703197A (nl) 1977-10-04
GB1580844A (en) 1980-12-03
US4031204A (en) 1977-06-21
LU77030A1 (ja) 1977-07-22
FR2346022A1 (fr) 1977-10-28
IE44911L (en) 1977-09-30
JPS6257307B2 (ja) 1987-11-30
DE2713371A1 (de) 1977-10-13
NZ183618A (en) 1979-12-11
JPS6216933B2 (ja) 1987-04-15
FR2346022B1 (ja) 1981-07-10
AU510744B2 (en) 1980-07-10
IE44911B1 (en) 1982-05-19
CA1085724A (en) 1980-09-16
ZA771893B (en) 1978-03-29
AU2329177A (en) 1978-09-21
BE852756A (fr) 1977-09-22
DE2713371C2 (ja) 1989-01-05

Similar Documents

Publication Publication Date Title
JPS5298392A (en) Inspired medicine inspirator
JPS52105162A (en) Phthleic derivatives and preparation thereof
JPS5373892A (en) Improved needle and attached ampule
ZA771593B (en) Hentriakontapeptides and methods for the preparation thereof
GB1556781A (en) Copolyester preparation and use thereof
JPS52105131A (en) Substituted phenylamidines and preparation thereof
JPS52120117A (en) Viral nasal cavity bronchitis vaccine and blended vaccine with kalicivirus
JPS52148617A (en) Vaccine and production thereof
ZA777611B (en) Cyclopentan-1-amines and the preparation thereof
ZA78757B (en) Respiratory sybcytial vaccine
HK60184A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
JPS5379841A (en) Aminoosugar derivative * its preparation and use
IL51864A (en) Rabies vaccine and its preparation
JPS52111552A (en) 44androstenee33one and preparation thereof
JPS5424896A (en) Benzodiazepineediones*preparation and use thereof
GB1519747A (en) 2 - arylpiperazine derivatives and the preparation thereo
JPS52131534A (en) Aralkylarylamine and preparation thereof
IL58947A (en) Vaccines against viral illnesses
JPS5291859A (en) 22furanones and preparation thereof
GB2004542B (en) Beta-substituted-diketones and preparation thereof
AU514767B2 (en) Premix for use with foodstuffs and vaccines
JPS5346977A (en) 55secondary alkylidenehydantoin and its preparation
JPS52100480A (en) Substituted ppaminophenyllasstriazinedione and its preparation
JPS54154492A (en) Modified novolak * preparation and use therefor
JPS54160088A (en) Cannula and its preparation